Lyophilization
| Category | Glossary |
|---|---|
| Also known as | Freeze-Drying, Freeze Drying, Lyophilized Powder |
| Last updated | 2026-04-13 |
| Reading time | 4 min read |
| Tags | storagepreparationstabilityglossary |
Overview
Lyophilization (commonly called freeze-drying) is a dehydration process used to preserve peptides, proteins, and other biological compounds by removing water from the material while it is in a frozen state. The process converts a liquid peptide solution into a dry, porous powder — often referred to as a lyophilized cake or lyophilized powder — that is significantly more stable during storage and transport than the original solution.
Nearly all research peptides are supplied in lyophilized form and must be reconstituted with an appropriate solvent, typically bacteriostatic water, before use.
Detailed Explanation
The Lyophilization Process
Lyophilization occurs in three distinct phases:
1. Freezing The peptide solution is cooled to a temperature well below its eutectic point (typically -40C to -80C). The water in the solution crystallizes into ice, while the peptide molecules become embedded within the ice matrix. The rate and method of freezing affect the final structure and quality of the lyophilized product.
2. Primary Drying (Sublimation) The chamber pressure is reduced to a deep vacuum (typically 50-200 mTorr), and gentle heat is applied. Under these conditions, the frozen water transitions directly from solid ice to water vapor without passing through a liquid phase — a process called sublimation. This phase removes approximately 95% of the water content and is the longest stage, often taking 24-48 hours.
3. Secondary Drying (Desorption) The temperature is raised further (often to 25-40C) while maintaining the vacuum to remove residual bound water molecules that did not crystallize during freezing. This step reduces the final moisture content to 1-3%, which is critical for long-term stability.
Why Lyophilization Is Necessary for Peptides
Peptides in aqueous solution are inherently unstable. Several degradation pathways are accelerated in the presence of water:
- Hydrolysis: Water molecules can attack peptide bonds, cleaving the chain and destroying biological activity.
- Deamidation: Asparagine and glutamine residues are susceptible to water-mediated deamidation, altering the peptide's charge and function.
- Oxidation: Dissolved oxygen in aqueous solutions can oxidize sensitive residues such as methionine and cysteine.
- Aggregation: Peptides in solution may form aggregates over time, particularly at higher concentrations or temperatures.
- Microbial growth: Aqueous solutions without preservatives are susceptible to bacterial contamination.
By removing water, lyophilization effectively halts or dramatically slows all of these degradation pathways.
Relevance to Peptide Research
Storage and Stability
Lyophilized peptides offer dramatically superior stability compared to peptides in solution:
| Condition | Lyophilized Powder | Reconstituted Solution |
|---|---|---|
| Room temperature | Weeks to months | Hours to days |
| Refrigerated (2-8C) | Months to years | Days to weeks |
| Frozen (-20C) | Years | Weeks to months |
These storage advantages are why virtually all commercial peptide suppliers ship their products in lyophilized form.
Reconstitution
Before use, lyophilized peptides must be reconstituted by adding an appropriate solvent. The standard procedure involves:
- Allowing the vial to reach room temperature to prevent condensation.
- Adding bacteriostatic water (or sterile water) slowly along the vial wall.
- Gently swirling — never shaking — to dissolve the powder completely.
- Storing the reconstituted solution refrigerated and using it within the solvent's preservative window.
The choice of reconstitution solvent matters. Bacteriostatic water (containing 0.9% benzyl alcohol) provides antimicrobial protection for multi-use vials, while sterile water is used for single-use preparations.
Quality Assessment
The quality of lyophilization can be assessed visually and analytically. A properly lyophilized peptide should appear as a uniform white to off-white powder or cake. A collapsed, discolored, or excessively powdery appearance may indicate suboptimal processing conditions. A certificate of analysis should accompany any research peptide, confirming that the lyophilized product meets purity specifications.
Examples
BPC-157 is typically supplied as a lyophilized powder in 5 mg vials. Once reconstituted with bacteriostatic water, the resulting solution should be refrigerated and used within approximately 3-4 weeks.
TB-500 (thymosin beta-4 fragment) is similarly supplied lyophilized. Its reconstituted solution is somewhat more stable than some smaller peptides due to its molecular structure, but refrigerated storage remains essential.
Growth hormone secretagogues such as Ipamorelin and CJC-1295 are also universally supplied in lyophilized form, underscoring the importance of this preservation technique across all categories of research peptides.
Related Terms
After lyophilization, peptides are reconstituted using bacteriostatic water. The purity and integrity of lyophilized products are documented in a certificate of analysis. Lyophilization helps preserve peptide bonds from hydrolytic degradation and maintains the compound's bioavailability when it is eventually administered.
Related entries
- Bacteriostatic Water— Sterile water containing 0.9% benzyl alcohol as a preservative, used as the standard solvent for reconstituting lyophilized peptides and allowing multi-dose use from a single vial.
- Bioavailability— The percentage of an administered compound that reaches systemic circulation in its active form, heavily influenced by the route of administration.
- Certificate of Analysis (COA)— A quality assurance document issued by a laboratory that verifies the identity, purity, and composition of a peptide product through standardized analytical testing methods.
- Half-Life— The concept of biological half-life as it applies to peptide pharmacokinetics — how long a compound remains active in the body and its implications for dosing frequency.